Huemer, F.; Lang, D.; Westphal, T.; Gampenrieder, S.P.; Hutarew, G.; Weiss, L.; Hackl, H.; Lamprecht, B.; Rinnerthaler, G.; Greil, R.
Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade. J. Clin. Med. 2019, 8, 1014.
https://doi.org/10.3390/jcm8071014
AMA Style
Huemer F, Lang D, Westphal T, Gampenrieder SP, Hutarew G, Weiss L, Hackl H, Lamprecht B, Rinnerthaler G, Greil R.
Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade. Journal of Clinical Medicine. 2019; 8(7):1014.
https://doi.org/10.3390/jcm8071014
Chicago/Turabian Style
Huemer, Florian, David Lang, Theresa Westphal, Simon Peter Gampenrieder, Georg Hutarew, Lukas Weiss, Hubert Hackl, Bernd Lamprecht, Gabriel Rinnerthaler, and Richard Greil.
2019. "Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade" Journal of Clinical Medicine 8, no. 7: 1014.
https://doi.org/10.3390/jcm8071014
APA Style
Huemer, F., Lang, D., Westphal, T., Gampenrieder, S. P., Hutarew, G., Weiss, L., Hackl, H., Lamprecht, B., Rinnerthaler, G., & Greil, R.
(2019). Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade. Journal of Clinical Medicine, 8(7), 1014.
https://doi.org/10.3390/jcm8071014